Classification for Staging and Managing Patients with Biopolymer-induced Human Adjuvant Disease

Biopolymer-induced human adjuvant disease (BHAD) is a chronic clinical condition that requires surgical intervention, regardless of the presence of symptoms, to minimize the risk of functional, aesthetic, and systemic sequelae and the development of conditions simulating autoimmune disease. We propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachón Suárez, Jaime Eduardo, Salazar, Marcela C., Rizo, Victor Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878701/
https://www.ncbi.nlm.nih.gov/pubmed/35233337
http://dx.doi.org/10.1097/GOX.0000000000004137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878701/
https://www.ncbi.nlm.nih.gov/pubmed/35233337
http://dx.doi.org/10.1097/GOX.0000000000004137

Ejemplares similares